BackReShape Lifesciences Overview

ReShape Lifesciences Current Cash

Track ReShape Lifesciences's current cash ($8.8M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$8.80M
↑ 249.73% YoYΔ $6.28M vs prior year quarter

Peer average

Loading

ReShape Lifesciences Current Cash History

Loading

ReShape Lifesciences vs. peers: Current Cash Comparison

Loading

ReShape Lifesciences Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

ReShape Lifesciences (RSLS) FAQ

ReShape Lifesciences (RSLS) currently reports a current cash of $8.8M as of March 2026. That compares with $2.5M in the prior-year period — up 249.7% year over year. Use the charts on this page to explore ReShape Lifesciences's current cash history and peer comparisons.

ReShape Lifesciences's current cash increased from $2.5M to $8.8M — a 249.7% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

ReShape Lifesciences reported $8.8M in current cash as of March 2026. That compares with $2.5M in the prior-year period — up 249.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $8.8M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for ReShape Lifesciences, and consider following RSLS for alerts when major investors trade the stock.

ReShape Lifesciences is classified in the Healthcare sector. On current cash, it currently shows $8.8M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RSLS with unrelated industries.